Skip to main content

Table 1 Patients characteristics

From: Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

Characteristics  
Median ECOG PS (range; PS 0/1/2) 1 (0–2; 10/40/5)
Median age (range) 62 (27–82)
Sex  
   men (%) 35 (64%)
   woman (%) 20 (36%)
Disease site (%)  
   Brain 2 (4%)
   Bone 11 (20%)
   Liver/viscera 23 (43%)
   Soft tissue/lung 18 (33%)
Pts metastatic sites (%)  
   1 16 (30%)
   > 1 39 (70%)
Median Disease Free Interval (range) 4 (0–240)
Nephrectomy (%)  
   Yes 50 (91%)
   No 5 (9%)